In recognition of Multiple Sclerosis Awareness Month in March, the MS Awareness Month campaign features a series of stories highlighting the real-life experiences of people affected by MS, written in their own words. Follow us on Facebook, Instagram, X, and Pinterest for more stories like this, using the hashtag #MSAwarenessMonth, or read the full series….
Fatigue..Are you tired of the lack of Progress in dealing with this?
Tweet As long as I can remember Fatigue has been a major issue for people with MS and it is a very underresearched and under-controlled sign of disease. This paper is a snap shot to see how badly we are dealing with it in the United Kingdom. It is online and free so you can…
The Power of Self-Advocacy: Finding Your Voice and Owning Your MS Journey
Self-advocacy is more than just a buzzword; it is the act of speaking up for yourself, clearly communicating your needs, and taking action to get what you want in life. At its core, it is about recognizing your own worth … Continue reading → Source: blog.mymsaa.org
MS study of genetic risk factors shows need for diverse data
While many genetic factors that increase the risk of multiple sclerosis (MS) are shared across ancestral backgrounds, a study identified a variant that may reduce MS risk in South Asian people, which had not been seen in European studies — suggesting that studies focusing mainly on people of European descent may miss less common genetic variants…
Is the Pharma CD20-antibody Fudge-All Cahones
Tweet Are all anti-CD20 the same? They all target the the same molecule i.e. CD20 binding due to the front end of the antibody and all have the same basic back end (Human IgG1) and all of them deplete the memory B cells. However, how they do this is different. How they are used and…
An MS diagnosis hasn’t stopped my world travels
In recognition of Multiple Sclerosis Awareness Month in March, the MS Awareness Month campaign features a series of stories highlighting the real-life experiences of people affected by MS, written in their own words. Follow us on Facebook, Instagram, X, and Pinterest for more stories like this, using the hashtag #MSAwarenessMonth, or read the full series….
New European patent covers all dosing regimens of experimental MS therapy
Immunic Therapeutics has been granted a new patent in Europe covering multiple dosing regimens of its experimental therapy vidofludimus calcium and related molecules for multiple sclerosis (MS) and other indications. The patent, titled “Dosage Regimen of Vidofludimus for Use in the Treatment of a Chronic Inflammatory and/or Autoimmune Diseases,” covers all relevant dosing regimens of…
My dysphagia from MS shows up during a difficult swallowing study
In the not-too-distant past, when my hands were still deft enough to use tools, I really enjoyed working on vehicles. The fact that they weren’t vehicles I depended on every day helped make it a hobby I enjoyed, rather than a chore. Like any hobby, it had its dull moments, but the only time it…
Brain volume loss may not reflect disability in progressive MS
Loss of brain volume (brain atrophy), a measure often used in clinical trials to track disease progression, may not accurately reflect worsening disability in people with primary progressive multiple sclerosis (PPMS). That’s according to a new analysis of data from the Phase 3 PROMISE trial, in which measures of brain atrophy were only poorly associated…
Along with hardships, my MS diagnosis has been a journey of learning
In recognition of Multiple Sclerosis Awareness Month in March, the MS Awareness Month campaign features a series of stories highlighting the real-life experiences of people affected by MS, written in their own words. Follow us on Facebook, Instagram, X, and Pinterest for more stories like this, using the hashtag #MSAwarenessMonth, or read the full series….